The introduction of biologic therapies (referred to as biologics), including tumor necrosis factor (TNF) inhibitors, interleukin (IL)-1 and IL-6 inhibitors, and B or T cell activation inhibitors, has had a significant impact on the treatment of RA. The gene discussed is TNF; the disease is rheumatoid arthritis.